ArticleFrontiers in cardiovascular medicine2021

Rivaroxaban Once-Daily vs. Dose-Adjusted Vitamin K Antagonist on Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF): Rationale and Design of an Investigator-Initiated Multicenter Randomized Prospective Open-Labeled Pilot Clinical Study.

Iksung Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.